News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Evotec AG (EVTG.F) Accelerates Growth Strategy of its Discovery Alliance Business with Acquisition of Indian RSIPL for EUR 2.8 Million in Cash



8/6/2009 8:55:49 AM

HAMBURG, Germany, Aug. 6, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) and DIL Limited, India, announced today the signing of a definitive agreement to acquire a 70% controlling majority stake of the drug discovery service company RSIPL for EUR 2.8 million in cash, a portion of which includes a potential earn-out.

Read at GlobeNewswire


comments powered by Disqus
Evotec AG
RSIPL
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES